CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)

Core Points - PreveCeutical Medical Inc. has announced the effective date of the reclassification and the plan of arrangement with BioGene Therapeutics Inc. to occur on November 25, 2025 [1][4]. Group 1: Arrangement Details - Under the Arrangement Agreement, 12,000,000 common shares of BioGene Therapeutics Inc. will be distributed to PreveCeutical shareholders [2][5]. - The arrangement will involve renaming PreveCeutical's current shares to 'Class A Common Shares without par value' and creating a new class of shares with identical terms and rights [2][5]. Group 2: Share Exchange - On the effective date, each PreveCeutical Current Share will be exchanged for one New PreveCeutical Share and 0.02 BioGene Spinout Shares, rounded down to the nearest whole share [3][6]. Group 3: Security Information - The old security name will remain as PreveCeutical Medical Inc. - Common Shares, with the anticipated payment date set for November 25, 2025, and the delist date on November 24, 2025 [7].